960119-75-9

960119-75-9 structure
960119-75-9 structure
  • Name: Fc 11a-2
  • Chemical Name: Fc 11a-2
  • CAS Number: 960119-75-9
  • Molecular Formula: C16H16N2
  • Molecular Weight: 236.31
  • Catalog: Signaling Pathways Immunology/Inflammation NOD-like Receptor (NLR)
  • Create Date: 2023-01-25 12:21:35
  • Modify Date: 2025-08-27 19:12:19
  • Fc 11a-2, a benzimidazole compound, is an orally active and potent NLRP3 inflammasome inhibitor. Fc 11a-2 restrains the formation of NLRP3 inflammasome by inhibiting activation of caspase-1 and thus the activation of IL-1b/IL-18. Fc 11a-2 prevents the development of Dextran sulfate sodium (DSS; HY-116282C)-induced murine experimental colitis[1][2][3].

Name Fc 11a-2
Description Fc 11a-2, a benzimidazole compound, is an orally active and potent NLRP3 inflammasome inhibitor. Fc 11a-2 restrains the formation of NLRP3 inflammasome by inhibiting activation of caspase-1 and thus the activation of IL-1b/IL-18. Fc 11a-2 prevents the development of Dextran sulfate sodium (DSS; HY-116282C)-induced murine experimental colitis[1][2][3].
Related Catalog
In Vitro Fc 11a-2 (10 μM) 抑制用 ATP 激活的 LPS (HY-D1056) 引发的 THP-1 细胞中释放 IL-1β 和 IL-18,IC50 约 10 μM[1]。
In Vivo Fc 11a-2 (3-30 mg/kg; 口服; 从第 1 天到第 10 天) 剂量依赖性地减轻由 DSS 诱导的体重减轻和结肠长度缩短[2]。 Animal Model: C57BL/6 mice induced Colitis with 2.5% DSS[2] Dosage: 3, 10, 30 mg/kg Administration: Orally; from day 1 to day 10 Result: Significantly attenuated the loss of body weight during the disease progression at 10 and 30 mg/kg. The myeloperoxidase (MPO) activity in colons at 10 and 30 mg/kg was lower than that of the vehicle-treated group. Significantly reduced the disease activity index, histopathologic scores and myeloperoxidase activity.
References

[1]. Liangkun Pan, et al. Synthesis and Biological Evaluation of Novel Benzimidazole Derivatives and Analogs Targeting the NLRP3 Inflammasome. Molecules. 2017 Jan 30;22(2):213.  

[2]. Wen Liu, et al. A novel benzo[d]imidazole derivate prevents the development of dextran sulfate sodium-induced murine experimental colitis via inhibition of NLRP3 inflammasome. Biochem Pharmacol. 2013 May 15;85(10):1504-12.  

[3]. Biswadeep Das, et al. Promise of the NLRP3 Inflammasome Inhibitors in In Vivo Disease Models. Molecules. 2021 Aug 18;26(16):4996.  

Molecular Formula C16H16N2
Molecular Weight 236.31
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.